SCHEMBL29256253

SCHEMBL29256253

CC1c2ccc(N)cc2N(Cc2ccccc2)C(=O)N1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.41
F2 P00734 1/20 0.41
PLG P00747 1/20 0.41
CTSG P08311 1/20 0.41
CMA1 P23946 1/20 0.41
CTRC Q99895 1/20 0.41
STING1 Q86WV6 1/20 0.41
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
GSK3A P49840 2/20 0.40
GSK3B P49841 2/20 0.40
MGLL Q99685 1/20 0.40
CACNA1G O43497 1/20 0.39
CACNA1H O95180 1/20 0.39
CACNA1I Q9P0X4 1/20 0.39
ACHE P22303 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
POLB P06746 1/20 0.38
ALDH1A1 P00352 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29256250 1.00 ELANE (0.41) ELANEF2PLGCTSGCMA1
SCHEMBL25138410 0.83 STING1 (0.48) STING1CACNA1GCACNA1HCACNA1IMEN1
SCHEMBL23769104 0.83 STING1 (0.48) STING1CACNA1GCACNA1HCACNA1IMEN1
SCHEMBL23769102 0.82 STING1 (0.50) STING1HPGDCACNA1GCACNA1HCACNA1I
SCHEMBL29256261 0.82 STING1 (0.50) STING1HPGDCACNA1GCACNA1HCACNA1I
SCHEMBL23769096 0.79 STING1 (0.49) STING1GSK3BCACNA1GCACNA1HCACNA1I
SCHEMBL23769101 0.79 STING1 (0.49) STING1GSK3BCACNA1GCACNA1HCACNA1I
SCHEMBL21932185 0.77 STING1 (0.61) STING1CACNA1GCACNA1HCACNA1IMEN1
SCHEMBL30128427 0.77 STING1 (0.61) STING1CACNA1GCACNA1HCACNA1IMEN1
SCHEMBL28913960 0.76 STING1 (0.40) ELANEF2PLGCTSGCMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118159535-A Small molecule STING antagonists 库拉德夫制药私人有限公司 2024-06-07 CN disclosed